JOY DE GUZMAN: Open Payments
NPI 1891173431 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 107 payments from 26 companies in 2025. Trend: 2023 $1,083 · 2024 $894 · 2025 $2,477
Food & beverage: $2,477
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $364 |
| Xeris Pharmaceuticals, Inc. | 9 | $205 |
| Abbott Laboratories | 8 | $196 |
| Sequel Med Tech, LLC | 9 | $189 |
| Ascendis Pharma Endocrinology Inc | 3 | $179 |
| Lilly USA, LLC | 9 | $158 |
| Amgen Inc. | 9 | $146 |
| Radius Health, Inc. | 5 | $119 |
| Insulet Corporation | 1 | $109 |
| Neurocrine BioSciences, Inc. | 4 | $106 |
Products named: Ozempic, FREESTYLE LIBRE 3, TWIIST, Yorvipath, MOUNJARO, Tymlos, TEPEZZA, RECORLEV.
Industry payments across TX — which companies pay providers there.
